Mazor Robotics Ltd. (Nasdaq: MZOR; TASE:MZOR) will
unveil its new Renaissance Guidance System brain module at the American Association of Neurological Surgeons (AANS) annual meeting in San Francisco. The US Food and Drug Administration (FDA) has approved the Renaissance system for both spine and brain surgery.
The Renaissance brain module utilizes a small, frameless platform with only three points of fixation to provide highly accurate access to the areas of the brain where intervention is needed. This helps to minimize incisions and scarring while providing surgeons with a full 360 degree working volume to change trajectories with ease.
"We are very happy to see the benefits that Renaissance Brain Surgery is bringing to neurosurgeons and their patients," said Mazor Robotics CEO Ori Hadomi. "After years of development, we are excited to introduce our technology to the brain surgery market and continue our efforts in this new arena."
To date, Mazor Robotics Renaissance Guidance System has been used to place over 45,000 implants in thousands of spine procedures worldwide.